Fritextsökning
Innehållstyper
-
The Swedish National Board of Health and Welfare rejects prioritising andrology as a speciality
Male infertility can be linked to a shorter lifespan and several severe diseases, but when couples who want children are examined, the focus is on the woman. Ex...
-
Pharma Outsourcing – Find the Right Partner (2026)
-
Scientific Solutions
-
ZEISS Hosts an exceptional Global Conference on Innovation and Production in Berlin
More than 50 distinguished speakers from leading manufacturing companies.
-
RegSmart Life Science AB
-
GSK acquires oncology research company
GSK acquires the American biotechnology company Idrx for up to 1.15 billion dollars.
-
Webinar: Automate your processes
Free ZEISS webinar on January 30th, 2025.
-
WuXi AppTec, UK Ltd
-
WuXi Biologics Germany GmbH
-
Novo Nordisk buys drug candidate in billion dollar deal
The Danish pharmaceutical giant Novo Nordisk have made an agreement with KBP Biosciences to aqcuire the hypertension drug ocedurenone for up to 1.3 billion doll...
-
Anna Törner: The minute between life and death
“I have never told anyone about this day that happened more than 20 years ago. But I sometimes reflect on what happened, on what might have happened. When I try...
-
Study: Cancer vaccine prolongs survival in difficult-to-treat tumour disease
According to a new study, a combination of a cancer vaccine from Norwegian company Ultimovacs and two immunotherapies significantly prolonged survival in cases ...
-
Medicon Valley Alliance
-
ZEISS O-INSPECT duo: The multifunctional measuring machine
ZEISS O-INSPECT duo combines advanced microscopy and metrology for impressive measurement accuracy.
-
Mercodia AB
-
About Microscope Ergonomics
Learn about ergonomic microscope design and how you can increase your well-being and productivity when working in clinical microscopy. Read about challenges, de...
-
Truly Labs AB
-
Galderma
-
SGS Fimko Ltd.
-
Aurevia
-
Moderna develops mRNA vaccine against norovirus
A highly anticipated vaccine is in late clinical evaluation and could be ready for approval within a couple of years. The target is the norovirus, often called ...
-
JMP Statistical Discovery
-
QPS Netherlands B.V
-
The Swedish innovation model: “There is a paradox”
It is often said that Sweden is strong when it comes to innovation, but how well are we turning that innovation into actual medicines?